|Day Low/High||118.31 / 121.43|
|52 Wk Low/High||72.67 / 128.57|
EBIX broke out on Tuesday in heavy volume, which hints at institutional buying in this stock.
Consider this strategy to help protect your portfolio as what could be a very treacherous earnings season approaches.
Despite the solid performance so far this year, there's still time to get on board and ride the profit train.
Money is still flowing into some market-moving names, but not into small-caps.
Alexion Pharma is too far above established support to be considered a buy at this point, so wait for a pullback closer to this key level.
If institutional buyers come into these stocks soon, we could have a nice year-end rally on our hands.
Focus on stocks that have come in no more than 30% off their recent highs as they have a good chance of forming sound bases and staging new breakouts.